| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $95.4M | -20.7% |
| R&D Expense | $9.6M | -25.4% |
| SG&A Expense | $52.1M | +3.8% |
| Operating Income | -$49.5M | -55.0% |
| Interest Expense | $16.5M | -30.1% |
| Pre-tax Income | -$66.5M | -761.5% |
| Income Tax | -$1.3M | -333.2% |
| Net Income | -$65.2M | -785.6% |
| EPS (Basic) | -$4.65 | -6742.9% |
| EPS (Diluted) | -$4.65 | -6742.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.3M | -15.6% |
| Short-term Investments | $2.0M | -65.6% |
| Accounts Receivable | $12.0M | -11.2% |
| Current Assets | $45.5M | -20.3% |
| Total Assets | $255.1M | -21.8% |
| Current Liabilities | $44.4M | -13.3% |
| Long-term Debt | $128.4M | -12.7% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.4M | -116.0% |
| Investing Cash Flow | $39.7M | -55.5% |
| Financing Cash Flow | -$32.8M | +54.0% |
| $193.2M |
| -15.4% |
| Stockholders' Equity | $62.0M | -36.7% |